| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3007147 |
| Synonym(s) | VNRX-5133 |
| Definition | Taniborbactam is a broad-spectrum beta-lactamase inhibitor. As of 2022, it is in phase III clinical trials in combination with cefepime and is the only beta-lactamase inhibitor exhibiting activity against all four classes of beta-lactamase. |
| SMILES | NCCN[C@H]1CC[C@@H](CC(=O)N[C@H]2Cc3cccc(C(=O)O)c3OB2O)CC1 |
| PubChem | 76902493 |
| ChEMBL | CHEMBL4584705 |
| Classification | 6 ontology terms | Show |
| Parent Term(s) | 11 ontology terms | Show + is_small_molecule_inhibitor_of NDM-2 + is_small_molecule_inhibitor_of SHV-5 + is_small_molecule_inhibitor_of OXA-1 + is_small_molecule_inhibitor_of OXA-48 + is_small_molecule_inhibitor_of CTX-M-15 + is_small_molecule_inhibitor_of CMY-2 + is_small_molecule_inhibitor_of IMP-1 + is_small_molecule_inhibitor_of VIM-2 + is_small_molecule_inhibitor_of KPC-2 + boronic acid beta-lactamase inhibitor + unclassified metallo-beta-lactamase inhibitor |
| Sub-Term(s) | 1 ontology terms | Show + cefepime-taniborbactam [Antibiotic+Adjuvant] has_part |
| Publications | Hamrick JC, et al. 2020. Antimicrob Agents Chemother 64(3): VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa. (PMID 31871094) |
| Curator | Description | Most Recent Edit |
|---|